Clinical trial
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer
NCT05082636 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 15, 2018
- Completion date
- March 25, 2021
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer